Results 81 to 90 of about 31,910 (237)
PRIMARY PULMONARY HODGKIN’S LYMPHOMA: RARE CLINICAL CASE
Паёми Сино, 2018 Lung involvement in Hodgkin’s lymphoma (HL) occurs from 15% to 40% of cases. In most patients, it is caused by germination of the affected mediastinal lymphatic nodes in the lung parenchyma. Primary pulmonary form of Hodgkin’s lymphoma is a rare disease:
E.O. RODIONOV +6 more
doaj +1 more source
Environmental chemicals and the tumor immune microenvironment
iMeta, EarlyView.Impact of representative environmental chemicals on tumor immune microenvironment (TIME). Representative environmental chemicals are ubiquitously distributed across air, soil, aquatic systems, and biota. These toxicants enter the human body via multiple exposure routes, including inhalation, dietary intake, and dermal absorption, subsequently ...
Tongtong Zhang +7 more
wiley +1 more source
Targeting the intratumoral microbiota to overcome cancer immunotherapy resistance
Interdisciplinary Medicine, EarlyView.This review delineates the mechanisms of intratumoral microbiota in cancer immunotherapy resistance, and offers strategies for microbiota‐targeted precision immunotherapy. Abstract Cancer remains a significant global health threat. The tumor microenvironment (TME) is a sophisticated ecological niche that exerts a pivotal effect on treatment outcomes ...
Bufu Tang +14 more
wiley +1 more source
Journal of Clinical Laboratory Analysis, EarlyView.Microbiota‐targeted therapeutic strategies in hematological disorders. aHSCT: Transplanted immune cells from the donor may attack the recipient's tissues, especially when damage to the intestinal epithelium disrupts the gut microbiota, contributing to GVHD. Maintaining a balanced gut microbiota that supports immune regulation helps reduce GVHD risk and
Alireza Molajafari +3 more
wiley +1 more source
Rare Case of Non-Hodgkin’s Lymphoma of the Thyroid
Online Journal of Health & Allied Sciences, 2020 Thyroid lymphoma is a rare cancer constituting 1% to 2% of all thyroid cancers and less than 2% of lymphomas. Thyroid Lymphomas are usually all Non-Hodgkin’s Lymphoma and most are B cell in origin.
Srirama Bhat +3 more
doaj
Advances in Hematology, 2011 From its first description by Thomas Hodgkin in 1832, Hodgkin's disease, now called Hodgkin's lymphoma, has continued to be a fascinating neoplasm even to this day.
Diponkar Banerjee
doaj +1 more source
JEADV Clinical Practice, EarlyView.ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley +1 more source
Hodgkin's disease and pregnancy: case series and proposal for treatment protocol
Einstein (São Paulo)The peak frequency of Hodgkin's disease convergesmatches with women of reproductive fertility age. Currently, this disease is the fourth more diagnosed neoplasia during pregnancy.
Carolina Kassab +4 more
doaj +1 more source
JEADV Clinical Practice, EarlyView.ABSTRACT Background Cutaneous T‐cell lymphoma (CTCL) is a rare and heterogeneous group of skin‐homing lymphomas with a largely unknown pathogenesis. Staphylococcus aureus (S. aureus) colonization has been implicated in exacerbating CTCL, particularly in advanced stages. Objectives This study assessed the prevalence of S.
Ida Lind Holm +9 more
wiley +1 more source
Intramuscular lymphoma: uncommon presentation of Hodgkin's disease. [PDF]
BMJ Case Rep, 2020 Alexander V +3 more
europepmc +1 more source